ACRES, ActivMed Focus on Site Accreditation, Standards
ActivMed will participate in ACRES ongoing Site Accreditation and Standards Initiative (SASI) to improve performance of global research sites through shared standards, accreditation, training and support.
The Alliance for Clinical Research Excellence and Safety (ACRES), a Massachusetts-based non-profit organization building a global system for clinical research and ActivMed Practices & Research, Inc., a woman-owned, for-profit, multi-specialty, free standing research organization based in Massachusetts and New Hampshire, announced a strategic alliance. ActivMed will participate in ACRES ongoing Site Accreditation and Standards Initiative (SASI) to improve performance of global research sites through shared standards, accreditation, training and support.
ActivMed participation will start with membership in a Phase III standards domain team involving personnel and professionalism criteria. With access to nearly one million patients in the Northeast region and a full range of clinical research studies (Phase I, II, III, IIIb and IV) performed on an inpatient and outpatient basis, ActivMed will also collaborate with ACRES in the testing of developed standards and processes for ACRES site accreditation work, professional development programs for research staff that can be offered within local communities as well as on line and the development of education and training programs ongoing at reasonable costs.
Read the full release.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
